Boehringer Ingelheim plans to submit its app to treat under-addressed symptoms of schizophrenia for FDA clearance.

Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through ...

AI use has exploded in radiology as the field struggles with staffing shortages, exacerbated by growing imaging volumes.

The CDC's ACIP panel voted to recommend delaying the birth dose of the hepatitis B vaccine, ending a policy that has reined ...

In today's Pharmalittle roundup, we're reading about FDA's Prasad defending his plans, a Merck setback in Germany, and more.

The future of children’s vaccines is on the agenda at today’s meeting of federal vaccine advisers, who are reviewing the ...

John Quackenbush built a lab that is at the forefront of human genetics research and bioinformatics. Trump administration ...

The complexity of developing and manufacturing, coupled with market and regulatory dynamics, has put biosimilars out of reach ...

We ask why so many Black and immigrant women avoid prenatal care. We should ask why they'd trust a system that often doesn’t ...

In a setback for Merck, a German court issued a preliminary injunction that prevents the company from distributing a new ...

There was a lot of talk among lawmakers on Thursday about extending the enhanced Affordable Care Act premium tax credits next ...

The FDA is warning people to stop using certain types of glucose monitor sensors after Abbott Diabetes Care said their ...